Anti-thymocyte Globulin (Rabbit)

N/A

Report date: 2026/04/25 20:00:23

Base Information

Drug NameAnti-thymocyte Globulin (Rabbit)
Drug Alias NameAntithymocyte globulin抗胸腺细胞球蛋白（兔）ThymoglobulineThymoglobulinrATG
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsRejection of pancreatic transplantationRejection of organ transplantationRejection of renal transplantation +[48] 
Global Approved IndicationsRejection of pancreatic transplantationRejection of organ transplantationRejection of renal transplantation +[9] 
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1998/12/30
Country/TerritoryCzechiaCanadaUnited States +[14] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesGenzyme Corp
China Registration ClassN/A

Develop Information

Active CompaniesSanofi Sa (Sanofi Ag)SanofiUniversity Of Florida +[4] 
Inactive CompaniesNational Institutes Of Health Clinical Center (Cc)Roswell Park Cancer InstituteWake Forest University Health Sciences +[23] 
Active IndicationsRejection of pancreatic transplantationRejection of organ transplantationRejection of renal transplantation +[11] 
Inactive IndicationsSolid tumoursImmunologic Deficiency SyndromesWolman Disease +[37] 

Other Information

ATC CodeL04AA04
Related LinksWikipediaDrugBankKEGG